@prefix orcid: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix rdf: .
@prefix xsd: .
@prefix rdfs: .
@prefix ns2: .
@prefix ns1: .
@prefix prov: .
@prefix ns3: .
@prefix npx: .
sub:Head {
this: np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo;
a np:Nanopublication .
}
sub:assertion {
sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
sub:version prov:value "1"^^xsd:integer .
rdf:object ns1:C0012634 "disease";
ns1:C0030705 "patients";
ns1:C0206419 "coronavirus";
ns1:C0206750 "coronavirus";
ns1:C5401375 "coronavirus" .
rdf:predicate ns2:TRIPLE_UID:falr4g99-TRIPLE-ABSTRACT-2 "see" .
rdf:subject ns1:C0011777 "dexamethasone";
ns1:C0026565 "mortality";
ns1:C0026566 "mortality";
ns1:C0814225 "benefits" .
rdfs:Triple-UID ns3:TRIPLE_UID:falr4g99-TRIPLE-ABSTRACT-2 "falr4g99-TRIPLE-ABSTRACT-2" .
rdfs:sentence rdfs:label "OBJECTIVES The questions remained if mortality benefits with dexamethasone seen in patients with coronavirus disease 2019 (COVID)-19) also extend to other systemic corticosteroids such as methylprednisolone." .
rdfs:triple rdfs:label "mortality benefits with dexamethasone seen in patients, with, coronavirus disease" .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2021-07-25T21:47:05.979318"^^xsd:dateTime .
}
sub:pubInfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
npx:hasSignature "f2y3VgBOpWjGcdGApp3dzSXawcDkA93W5f43ExbFjPbF4kC1SXdoly0gXmL9ZOxr0VgnS48fkScfSFMmzKPHkwKyDvvFs/7vK8yVLVIsPepMctaD8xLanKaxoUuSA7pj4FBruSM5B3N4euHg6Cp9OMXBu3jL3tmLdEyrXfpvY14=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2021-07-25T21:47:05.979318"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}